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Abstract
Background: Studies in the United States show that rural persons with HIV are more likely than their urban
counterparts to be diagnosed at a late stage of infection, suggesting missed opportunities for HIV testing in rural
areas. To inform discussion of HIV testing policies in rural areas, we generated nationally representative, population-
based estimates of HIV testing frequencies in urban vs. rural areas of the United States.
Methods: Secondary analysis of 2005 and 2009 Behavioral Risk Factor Surveillance System (BRFSS) data. Dependent
variables were self-reported lifetime and past-year HIV testing. Urban vs. rural residence was determined using the
metropolitan area framework and Urban Influence Codes and was categorized as 1) metropolitan, center city (the
most urban); 2) metropolitan, other; 3) non-metropolitan, adjacent to metropolitan; 4) non-metropolitan,
micropolitan; and 4) remote, non-metropolitan (the most rural).
Results: The 2005 sample included 257,895 respondents. Lifetime HIV testing frequencies ranged from 43.6%
among persons residing in the most urban areas to 32.2% among persons in the most rural areas (P < 0.001). Past-
year testing frequencies ranged from 13.5% to 7.3% in these groups (P < 0.001). After adjusting for demographics
(age, sex, race/ethnicity, and region of residence) and self-reported HIV risk factors, persons in the most remote
rural areas were substantially less likely than persons in the most urban areas to report HIV testing in the past year
(odds ratio 0.65, 95% CI 0.57-0.75). Testing rates in urban and rural areas did not change substantively following the
2006 Centers for Disease Control and Prevention recommendation for routine, population-based HIV testing in
healthcare settings. In metropolitan (urban) areas, 11.5% (95% CI 11.2-11.8) reported past-year HIV testing in 2005
vs. 11.4% (95% CI 11.1%-11.7%) in 2009 (P = 0.93). In non-metropolitan areas, 8.7% (95% CI 8.2%-9.2%) were tested
in 2005 vs. 7.7% (95% CI 7.2%-8.2%) in 2009 (P = 0.03).
Conclusions: Rural persons are less likely than urban to report prior HIV testing, which may contribute to later HIV
diagnosis in rural areas. There is need to consider strategies to increase HIV testing in rural areas.
Background
Over the past three decades the human immunodefi-
ciency virus (HIV) epidemic in the United States (US)
has slowly but persistently spread from large cities to
involve more rural areas. The Centers for Disease Con-
trol and Prevention (CDC) now estimate that 8-9% of
persons with newly diagnosed Acquired Immune Defi-
ciency Syndrome (AIDS)-an advanced stage of HIV
infection-reside in non-metropolitan (rural) areas [1]. In
comparison, 17% of the US population resides in non-
metropolitan areas [2].
Rural persons with HIV are more likely than their
urban counterparts to be diagnosed and enter care at
advanced stages of infection [3,4]. This is significant
because later diagnosis is associated with both worse
outcomes and increased HIV transmission [5]. Later
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are less likely to have an HIV test during the early, gen-
erally-asymptomatic years of infection, and indicates a
need for strategies to increase HIV testing in rural
populations.
An analysis of National Health Interview Survey
(NHIS) data from 1991-prior to the availability of effec-
tive HIV therapy-found that rural persons were less
likely than urban to report prior HIV testing [6]. How-
ever, there are no published reports of the frequency of
HIV testing in urban vs. rural areas of the US in the
modern era of effective HIV therapy and increased
emphasis on HIV testing. Thus, there is need to update
prior studies with more recent data on HIV testing fre-
quencies in rural compared to urban areas.
In an effort to inform discussion about HIV testing
strategies in rural areas, we analyzed national Behavioral
Risk Factor Surveillance System (BRFSS) data with two
goals: 1) to determine self-reported HIV testing frequen-
cies in urban compared to rural populations of the US
in the modern era of effective HIV therapy, and 2) to
determine the types of sites where HIV testing is occur-
ring in urban vs. rural areas.
Methods
Data sources and population
This study used publically-available BRFSS data to gen-
erate nationally-representative, cross-sectional estimates
of the frequency of HIV testing in the US population in
2005 and 2009, according to urban vs. rural residential
status. BRFSS is an annual, random-digit-dialed tele-
phone survey of the US civilian, non-institutionalized
population aged ≥ 18 years [7]. State-level data are com-
bined and weighted to create a nationally representative
sample. Survey response rates during these years ranged
from 51% to 53% [8]. We also obtained the non-public
use BRFSS data for 2005 that included Federal Informa-
tion Processing Standard (FIPS) county codes and used
these to link data for each respondent with county-
based Urban Influence Codes (UIC) developed by the
United States Department of Agriculture [9]. This
allowed more precise classification of urban vs. rural
residence. CDC policy did not allow release of non-pub-
lic 2009 BRFSS data including county codes, thus pre-
venting linkage to UICs for this year.
Variables
The primary dependent variables were dichotomous
measures indicating whether respondents reported HIV
testing in the past 12 months or ever in their lifetime.
BRFSS limited questions regarding HIV testing to adults
age 18-64 and excluded HIV tests performed during
blood donation. Persons with missing HIV-testing data
due to refusal to answer questions or uncertainly
regarding prior testing (~ 2% of respondents) were
excluded. This follows the approach applied in prior
reports of HIV testing rates in CDC survey data [10].
Among respondents reporting a prior HIV test, BRFSS
also asked “Where did you have your last HIV test: at a
private doctor or HMO office, at a counseling and test-
ing site, at a hospital, at a clinic, in a jail or prison, at
home, or somewhere else?” We combined responses to
create a six-level categorical variable for the type of site
where the HIV test occurred: 1) outpatient healthcare
setting (private doctor, HMO office, or clinic), 2) hospi-
tal, 3) counseling and testing site, 4) home, 5) other,
and 6) not sure.
The primary independent variable was a measure of
respondent urban vs. rural residence that followed the
metropolitan area framework developed by the US
Office of Management and Budget in 2003, based on
2000 Census data [2]. The metropolitan area framework
is a commonly used measure of urban ("metropolitan”)
vs. rural ("non-metropolitan”)e n v i r o n m e n t si nt h eU S .
In each year, BRFSS classified respondents as living in
the center city of a metropolitan area, in a metropolitan
area but not in a center city, or in a non-metropolitan
area. For 2005 data, we used UICs linked to county
codes to further classify non-metropolitan areas. These
codes combined population and commuting data to pro-
vide more precise definitions of stages along the urban-
rural continuum [9]. Urban influence codes were not
available for the state of Alaska.
This allowed creation of a five-level variable describing
respondent urban vs. rural residence: 1) metropolitan-
center city (the most urban), 2) metropolitan-other
(including suburban areas), 3) non-metropolitan-but
adjacent to a metropolitan area (UICs 3-7), 4) non-
metropolitan-micropolitan (not adjacent to a metropoli-
tan area but with a town/urban cluster of 10,000 resi-
dents or greater, UIC 8); or 5) remote non-metropolitan
(the most rural, UIC 9-12). It was not possible to link
Urban Influence Codes to 2009 data. For analysis of
2009 data we classified respondents simply as metropoli-
tan or non-metropolitan.
Covariates were selected from prior reports of factors
associated with HIV testing rates in CDC survey data,
including BRFSS and the National Health Interview
Study (NHIS) [10,11]. These included self-reported age,
gender, race-ethnicity (classified as White, non-Hispanic;
Black, non-Hispanic; Hispanic; or other), region of the
United States by census criteria (Northeast, South, Mid-
west, and West), and self-reported presence of HIV risk
factors. Respondents were asked whether they had any
of the following HIV risk factors in the past year: intra-
venous drug use, treatment for a sexually transmitted
infection, exchange of money or drugs for sex, or anal
sex without a condom. Responses were used to create a
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of HIV risk factors.
Analysis
We first examined 2005 BRFSS data, the most recent
year for which Urban Influence Codes allowed more
precise definition of urban vs. rural residence. We deter-
mined demographic characteristics (age, gender, race/
ethnicity, and region of residence) and frequency of HIV
risk factors among US adults age 18-64 according to
urban vs. rural residential status. We next determined
the frequencies of lifetime and past year HIV testing in
2005 by metropolitan status. We also determined the
type of site where the HIV test occurred according to
respondent residential status. Sample weights allowed
generation of nationally representative estimates. Cate-
gorical measures were compared using chi-square statis-
tics and continuous measures using rank-sum tests. All
analyses accounted for the complex survey design using
SUDAAN software v. 9 (Research Triangle Park, NC).
We next used 2005 data to fit logistic regression mod-
els to determine the association between residential sta-
tus and HIV testing in the past year after adjusting for
possible confounders, including age, gender, race/ethni-
city, region, and presence of HIV risk factors. We exam-
ined all variables for collinearity (correlation coefficient
> 0.5). Models were developed through backwards elimi-
nation, beginning with testing for interactions between
residence and other variables using a cutoff of P < 0.01
for significance. We fitted two multivariate models: 1)
including rural vs. urban residence and demographics
(age, race/ethnicity, sex, and region), and 2) including
rural vs. urban residence, demographics, and presence of
a self-reported HIV risk factor.
In order to determine whether differences in HIV test-
ing rates between urban and rural populations were
stable over time, we also examined HIV testing rates
according to residential status using 2009 BRFSS data,
the most recent year available. As it was not possible to
further classify residential status in 2009 according to
UIC, we categorized respondents as simply metropolitan
("urban”) or non-metropolitan ("rural”).
Results
The 2005 sample included 257,895 respondents who
were representative of the entire US population, exclud-
ing Alaska. As the residential environment became pro-
gressively more rural, respondents were older, more
likely to be white, more likely to live in the South or Mid-
west, less likely to live in the Northeast or West, and less
likely to self-report an HIV risk factor (Table 1).
Both lifetime and past-year HIV testing rates varied
significantly along the urban-rural continuum (Figure 1).
Residents of the United States were progressively less
likely to report prior HIV testing as their environment
became more rural. Lifetime testing frequencies ranged
from 43.6% among persons residing in center cities of
metropolitan areas (the most urban areas) to 32.2%
among persons in remote non-metropolitan regions (the
most rural areas). Past-year testing frequencies ranged
from 13.5% to 7.3% in these groups (P < 0.001 for both
comparisons).
All variables were significant in the multivariable mod-
els and there were no significant interactions between
residence and covariates. Model #1 indicated that demo-
graphic characteristics substantially confounded the
association between rural vs. urban residence and HIV
testing, as indicated by attenuation of the effects related
Table 1 Characteristics of U.S. Adults Age 18-64 in 2005, by Metropolitan Residence
METROPOLITAN NON-METROPOLITAN
p Overall
N = 257,895
Central City
N = 84,492
Other
N = 92,818
Adjacent
N = 44,096
Micropolitan
N = 20,584
Remote
N = 15,905
Age, Median (IQR) < 0.001 39 (29-50) 38 (28-49) 40 (30-50) 41 (29-51) 41 (29-51) 42 (30-52)
Race/ethnicity, % (SE) < 0.001
White, non-Hispanic 68.5 (0.2) 56.8 (0.4) 73.1 (0.3) 82.9 (0.4) 81.4 (0.6) 85.5 (0.6)
Black, non-Hispanic 10.1 (0.1) 14.7 (0.2) 7.4 (0.2) 7.2 (0.2) 5.9 (0.3) 5.4 (0.6)
Hispanic 15.5 (0.2) 21.2 (0.4) 14.2 (0.3) 6.0 (0.3) 7.9 (0.5) 5.6 (0.4)
Other 5.2 (0.1) 6.6 (0.2) 4.7 (0.2) 3.3 (0.2) 4.1 (0.4) 3.1 (0.3)
Unknown 0.7 (0.1) 0.7 (0.1) 0.6 (0.1) 0.6 (0.1) 0.7 (0.1) 0.4 (0.1)
Sex, % Female (SE) .96 50.0 (0.2) 50.0 (0.3) 50.0 (0.3) 50.3 (0.5) 50.3 (0.7) 49.8 (0.7)
Region, % (SE) < 0.001
Northeast 18.6 (0.1) 15.4 (0.2) 24.0 (0.2) 15.2 (0.3) 8.5 (0.3) 5.1 (0.3)
South 35.8 (0.1) 36.7 (0.3) 32.2 (0.2) 45.5 (0.4) 33.7 (0.6) 42.1 (0.7)
Midwest 22.3 (0.1) 19.1 (0.2) 21.7 (0.2) 28.1 (0.4) 36.0 (0.6) 38.2 (0.7)
West 23.2 (0.1) 28.8 (0.3) 22.1 (0.3) 11.2 (0.3) 21.8 (0.5) 14.6 (0.5)
HIV Risk Factor, % (SE) < 0.001 4.0 (0.1) 4.7 (0.2) 3.7 (0.2) 3.3 (0.2) 3.3 (0.3) 2.9 (0.3)
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HIV testing was more common among younger persons,
Blacks, Hispanics, and women [10,11]. Additional
adjustment for self-reported HIV risk factors in model
#2 led to less substantial change in the association
between rural vs. urban residence and HIV testing.
After adjusting for demographic characteristics (age,
race/ethnicity, sex, region) and self-reported presence of
an HIV risk factor, the likelihood of HIV testing in the
past year decreased progressively as respondent resi-
dence became more rural (adjusted odds ratio for
respondents in remote non-metropolitan regions com-
pared to center city of metropolitan areas 0.65, 95% CI
0.57-0.75).
The type of site where the test occurred also varied by
respondent residence. In general, rural persons with a
prior HIV test were less likely to report testing in an
outpatient medical clinic or HIV counseling and testing
site, but more likely to report testing in a hospital
(Table 3).
Past year HIV testing rates did not change substan-
tially between 2005 and 2009 in either urban or rural
areas (Figure 2). In the metropolitan (urban) group
11.5% (95% CI 11.2-11.8) reported past-year HIV testing
in 2005 vs. 11.4% (95% CI 11.1%-11.7%) in 2009 (P =
0.93). Testing rates actually declined slightly in the non-
metropolitan (rural) group; 8.7% (95% CI 8.2%-9.2%)
were tested in 2005 vs. 7.7% (95% CI 7.2%-8.2%) in 2009
(P = 0.03).
Discussion
In this nationally-representative, population-based study
of HIV testing frequencies in the United States, we
found that the frequency of self-reported HIV testing
decreased substantially as the residential environment
became progressively more rural. After adjusting for dif-
ferences in demographics and self-reported HIV risk
factors, the odds of HIV testing in the past year were
35% lower among persons living in the most remote
rural areas compared to persons in the most urban
areas. Rural persons with a prior HIV test were more
likely than urban to report testing in a hospital, but less
likely in the outpatient setting.
A prior study in the early years of the HIV epidemic
in the US also found that rural persons were less likely
than urban to report HIV testing [6]. Our results
demonstrate that this gap in testing persists in the mod-
ern era of effective HIV therapy, when early diagnosis
and linkage to care are even more essential. Moreover,
recent efforts to increase testing have not impacted the
rural-urban gap in testing. Although rural persons with
HIV experience barriers to care, prior studies have
described effective models for delivering high-quality
HIV care in rural settings [12-18]. This accentuates the
importance of early testing and diagnosis among rural
persons with HIV.
The observation of lower HIV testing rates in rural
areas is consistent with published evidence that rural
persons are, on average, diagnosed with HIV at a later
stage of infection than urban persons [4]. Persons diag-
nosed at a later stage of HIV infection experience worse
outcomes than persons diagnosed early and may
unknowingly transmit infection to others [19,20]. Thus,
there is pressing need for efforts to promote increased
HIV testing and earlier diagnosis in rural areas.
Lower rates of HIV testing in rural areas may result
from decreased access to settings where testing occurs,
including both healthcare delivery sites and community-
based HIV counseling and testing programs. In addition,
rural healthcare providers may have less experience in
HIV medicine and be less likely to recommend testing
[12]. Stigma surrounding HIV infection may make rural
persons less likely to seek testing [15]. Such stigma is
intensified in rural areas due to a perceived lack of
anonymity and fear that privacy will be lost when seek-
ing testing [21,22].
What is the optimal frequency of HIV testing in rural
populations in the US? Until recently, the US has pur-
sued a risk-based approach to HIV testing. Prior to
2006, the CDC recommended HIV testing for persons
with identified risk factors, including persons with his-
tory of intravenous drug use or sexually transmitted
infections, men who have sex with men, persons who
have exchanged sex for money or drugs, or their sex
partners [23]. Under this approach, HIV testing rates
would naturally be lower in rural areas, where fewer
persons report HIV risk factors. However, using 2005
data when risk-based testing policies were in place, we
found that even after adjusting for differences in self-
reported HIV risk factors and demographics, rural per-
sons were substantially less likely to report HIV testing
than urban persons.
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Figure 1 Lifetime and past-year HIV testing frequencies among
US adults age 18-64 in 2005, by metropolitan residence.
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mended routine, voluntary HIV testing in the healthcare
setting for all persons between ages 13 and 64 [24]. This
change in policy reflected growing recognition that risk-
based HIV testing strategies were inadequate. Despite
prior risk-based testing policies, nearly half of persons
with newly-diagnosed HIV infection were recognized
late in their course and met criteria for Acquired
Immune Deficiency Syndrome (AIDS)-an advanced
stage of immune compromise-within a year of HIV
diagnosis [25]. Many had missed opportunities for HIV
testing and earlier diagnosis during prior healthcare
encounters, in part due to lack of perceived risk for HIV
infection or reluctance to disclose HIV risk factors to
providers [5,25]. Routine testing seeks to remove stigma
associated with identifying persons with HIV risk factors
for testing, which may particularly increase testing
among persons who are at risk for infection but who do
not report risk factors. The overall goal of routine test-
ing in healthcare settings is to increase the frequency of
Table 2 Univariate and Multivariate Odds Ratios for Past Year HIV Testing among U.S. Adults Age 18-64
Univariate OR* Multivariate OR*
Model #1
†
Multivariate OR*
Model #2
‡
Urban-rural residence
Metropolitan, center city Ref Ref Ref
Metropolitan, other 0.68 (0.64-0.73) 0.78 (0.73-0.85) 0.81 (0.75-0.87)
Non-metro, adjacent 0.61 (0.56-0.67) 0.75 (0.68-0.83) 0.77 (0.70-0.84)
Non-metro, micropolitan 0.63 (0.55-0.73) 0.78 (0.67-0.91) 0.80 (0.70-0.93)
Non-metro, remote 0.50 (0.44-0.57) 0.62 (0.54-0.73) 0.65 (0.57-0.75)
Age
18-24 5.46 (4.85-6.15) 5.21 (4.60-5.90) 4.87 (4.30-5.51)
25-34 4.89 (4.40-5.44) 4.61 (4.13-5.16) 4.47 (3.99-5.00)
35-44 2.95 (2.65-3.29) 2.86 (2.56-3.20) 2.82 (2.52-3.16)
45-54 1.60 (1.43-1.80) 1.59 (1.41-1.79) 1.57 (1.39-1.77)
55-64 Ref Ref Ref
Race/ethnicity
White, non-hispanic Ref Ref Ref
Black, non-hispanic 3.90 (3.6-4.2) 3.37 (3.12-3.64) 3.33 (3.08-3.59)
Hispanic 1.94 (1.77-2.13) 1.49 (1.35-1.65) 1.46 (1.32-1.62)
Other 1.43 (1.22-1.70) 1.26 (1.08-1.48) 1.23 (1.05-1.45)
Unknown 1.20 (0.9-1.6) 1.15 (0.85-1.56) 1.15 (0.86-1.55)
Sex, female 1.09 (1.03-1.20) 1.10 (1.05-1.20) 1.10 (1.04-1.20)
Region
Northeast Ref Ref Ref
South 1.18 (1.10-1.27) 1.01 (0.93-1.09) 1.01 (0.94-1.10)
Midwest 0.71 (0.65-0.77) 0.71 (0.65-0.78) 0.71 (0.65-0.77)
West 0.95 (0.86-1.05) 0.89 (0.80-0.99) 0.88 (0.80-0.98)
HIV risk factor 2.88 (2.54-3.26) *** 2.08 (1.82-2.38)
* OR = odds ratio and 95% confidence interval
† Model #1:residence and demographics
‡ Model #2:residence, demographics, and HIV risk factor
Table 3 Type of HIV testing site by respondent residence (% of persons reporting test)
Metropolitan Non-Metropolitan
p Overall Central City Other Adjacent Micropolitan Remote
Testing Location < 0.001
Outpatient clinic 64.3 66.0 64.0 60.8 60.0 57.8
Hospital 18.4 17.2 18.1 22.6 21.7 24.9
Counseling/testing site 3.3 4.0 3.0 2.1 2.7 2.0
Home 4.0 3.5 4.7 3.9 3.6 4.1
Other 8.7 8.2 8.8 9.5 11.0 10.0
Not sure 1.3 1.1 1.4 1.1 1.0 1.2
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ing the likelihood that persons in early stages of HIV
infection undergo testing and preventing late diagnosis.
The rate of HIV testing did not change substantively
in either urban or rural areas between 2005 and 2009,
when routine testing policies had been in place for sev-
eral years. In fact, the frequency of past-year testing
declined slightly in rural areas. This indicates that the
routine testing recommendation did not meaningfully
impact the tendency toward less HIV testing in rural
areas. Regardless of whether one views our results from
a risk-based or population-based testing perspective,
there is a substantial gap in HIV testing rates between
urban and rural areas.
The relevance of CDC’s routine testing policy to rural
areas is unclear. Although modeling indicates that rou-
tine testing is cost-effective, with estimates generally less
than $70,000 per Quality-adjusted life year (QALY)
gained compared to prior testing policies, cost-effective-
ness worsens as the prevalence of undiagnosed HIV
infection in the local population decreases [26]. Preva-
lence of undiagnosed HIV infection is generally
unknown in rural areas of the US, but is probably often
significantly less than 0.1%. This mitigates the public
health impact of routine HIV-testing in rural healthcare
settings.
On the other hand, cost-effectiveness of routine test-
ing improves as the background rate of HIV testing in
the community decreases, leading to HIV diagnosis at a
later stage of infection for many persons [26]. It is
important to note that cost-effectiveness of routine HIV
testing may be favorable in rural areas with low back-
ground rates of HIV testing and correspondingly high
rates of late HIV diagnosis, even when local prevalence
of undiagnosed HIV infection is low. To address this
possibility, future studies should use HIV surveillance
data, which are now geocoded in many states, and pub-
lished mathematical models to explore the cost-effec-
tiveness of routine HIV testing across a range of rural
healthcare settings.
This study has several limitations. BRFSS relied on
self-report of HIV testing and risk factors. Respondents
may have had inaccurate awareness or recall of prior
HIV testing. Stigma related to HIV infection may have
made respondents reluctant to disclose information
regarding HIV risk factors in a telephone survey. Disclo-
sure of HIV risk factors is also incomplete during
healthcare encounters and revised testing guidelines
now emphasize population-based instead of risk-based
HIV testing [5]. We therefore believe that the popula-
tion-based HIV testing frequencies reported here are
relevant, even if adjustment for HIV risk-factors was
imperfect.
CDC recommendations call for routine HIV testing in
the healthcare setting for persons age 13-64, but BRFSS
did not include persons under age 18. BRFSS also did
not include persons who were homeless, incarcerated, in
the military, or in long-term care facilities. These are
important populations when considering HIV testing
policies.
BRFSS employs random-digit-dialing of land-based tel-
ephones. An increasing segment of the US population
uses cell phones only, and this population is younger
and displays differing health behavior patterns than
land-line users [7]. Future studies of HIV testing fre-
quencies would benefit from strategies to sample
younger populations at increased risk for HIV infection,
such as use of cell-phone and internet-based survey
techniques [7]. Finally, this was a cross-sectional analy-
sis. A cohort study analyzing time to HIV testing among
rural and urban persons (survival analysis) may provide
better estimates of testing discrepancies and avoid biases
due to migration and loss to follow up.
Conclusions
Previous work indicates that rural persons with HIV are
more likely than their urban counterparts to be diag-
nosed at a late stage of infection, suggesting missed
opportunities for HIV testing in rural areas. Our results
confirm that both overall and risk-factor-adjusted HIV
testing rates are lower in rural compared to urban popu-
lations in the US. Together, these findings demonstrate
a pressing need to develop and implement cost-effective
strategies to increase HIV testing, whether risk-based or
routine, that are tailored to the unique needs of the
rural setting. Potential strategies to increase HIV testing
in rural areas include: 1) implementation of nurse-
Figure 2 Frequency of past-year HIV testing in 2005 vs. 2009,
by metropolitan residence.
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gration of testing into a range of easily-accessible health
services, such as community pharmacies, and 3) use of
rapid HIV testing [21,27].
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